Mayne Pharma Group (AU:MYX)

Mayne Pharma Group (MYX) Income Statement


Mayne Pharma Group Income Statement

Last quarter (Q4 2022), Mayne Pharma Group's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Mayne Pharma Group's net income was AU$―. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-AU$ 423.92MAU$ 400.32MAU$ 456.60MAU$ 523.96MAU$ 529.14M
Cost of Revenue
-AU$ 253.77MAU$ 205.58MAU$ 231.49MAU$ 222.60MAU$ 266.26M
Gross Profit
-AU$ 170.15MAU$ 194.74MAU$ 225.11MAU$ 301.36MAU$ 262.88M
Operating Expense
-AU$ 171.69MAU$ 173.44MAU$ 226.60MAU$ 278.92MAU$ 225.13M
Operating Income
-AU$ -1.54MAU$ 21.30MAU$ -1.49MAU$ 22.44MAU$ 37.76M
Net Non Operating Interest Income Expense
-AU$ -31.97MAU$ -32.13MAU$ -30.75MAU$ -16.43MAU$ -17.14M
Other Income Expense
-AU$ -204.20MAU$ -253.06MAU$ -110.62MAU$ -359.66MAU$ -187.35M
Pretax Income
-AU$ -217.82MAU$ -263.89MAU$ -135.37MAU$ -353.72MAU$ -166.79M
Tax Provision
-AU$ 56.13MAU$ -54.80MAU$ -40.83MAU$ -69.97MAU$ -32.53M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
-AU$ -263.34MAU$ -208.42MAU$ -92.79MAU$ -280.87MAU$ -133.98M
Basic EPS
-AU$ -3.20AU$ -0.13AU$ -0.06AU$ -0.19-
Diluted EPS
-AU$ -3.20AU$ -0.13AU$ -0.06AU$ -0.19-
Basic Average Shares
-AU$ 82.30MAU$ 1.57BAU$ 1.53BAU$ 1.48B-
Diluted Average Shares
-AU$ 82.30MAU$ 1.57BAU$ 1.53BAU$ 1.48B-
Dividend Per Share
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00-
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
Net Income From Continuing And Discontinued Operation
-AU$ -263.34MAU$ -208.42MAU$ -92.79MAU$ -280.87MAU$ -133.98M
Normalized Income
-AU$ -145.12MAU$ -19.20MAU$ -17.84MAU$ 1.28MAU$ 19.13M
Interest Expense
-AU$ 32.10MAU$ 32.35MAU$ 31.06MAU$ 17.44MAU$ 17.25M
-AU$ -185.72MAU$ -231.54MAU$ -104.31MAU$ -336.27MAU$ -149.54M
-AU$ -104.64MAU$ -163.35MAU$ -19.75MAU$ -241.78MAU$ -71.83M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis